The development of a serum-free derived bioengineered conjunctival epithelial equivalent using an ultrathin poly(ε-caprolactone) membrane substrate

被引:69
作者
Ang, LPK
Cheng, ZY
Beuerman, RW
Teoh, SH
Zhu, X
Tan, DTH
机构
[1] Singapore Natl Eye Ctr, Singapore 168751, Singapore
[2] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore
[3] Natl Univ Singapore, Dept Engn Mech, Singapore 117548, Singapore
[4] Singapore Eye Res Inst, Singapore, Singapore
关键词
D O I
10.1167/iovs.05-0512
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To evaluate the use of an ultrathin poly( epsilon-caprolactone) (PCL) membrane as a substrate for the development of a serum-free-derived conjunctival epithelial equivalent. METHODS. Ultrathin PCL membranes 6 mu m in thickness were prepared by solvent casting and biaxial stretching and analyzed by atomic force microscopy (AFM), scanning electron microscopy (SEM), tensile testing, and water-contact angle measurement. Rabbit conjunctival epithelial cells were cultivated on sodium hydroxide (NaOH)-treated PCL membranes and untreated PCL membranes in serum-free medium. The proliferative capacity of cultivated cells was analyzed with a bromodeoxyuridine (BrdU) ELISA proliferation assay. Conjunctival equivalents were xenografted into severe combined immunedeficient (SCID) mice. Immunostaining for tissue-specific and basement membrane-related proteins was performed. RESULTS. After biaxial stretching, the tensile strength of PCL membranes increased from 21 to 42 MPa, with a Young's modulus of 225 MPa. AFM and SEM showed that biaxially stretched PCL membranes consisted of closely packed microfibrils. PCL membranes supported the attachment and proliferation of conjunctival epithelial cells to form confluent stratified epithelial sheets. Surface modification with NaOH resulted in greater hydrophilicity and cellular proliferation than that of untreated membranes. Transplanted conjunctival equivalents underwent greater proliferation and stratification in vivo. Cultivated conjunctival cells expressed K4, K19, MUC5AC, and Ki67, whereas collagen IV and integrin beta 4 were detected at the basement membrane junction. CONCLUSIONS. An ultrathin PCL membrane was shown to be biocompatible, mechanically strong enough to stand up to handling, and able to support conjunctival epithelial cell proliferation. This membrane may have potential for use as a scaffold matrix for tissue-engineered conjunctival equivalents.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 38 条
[21]  
Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
[22]  
Naughton G, 1997, ARTIF ORGANS, V21, P1203
[23]   Simultaneous biaxial drawing of poly (ε-caprolactone) films [J].
Ng, CS ;
Teoh, SH ;
Chung, TS ;
Hutmacher, DW .
POLYMER, 2000, 41 (15) :5855-5864
[24]   Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium [J].
Pellegrini, G ;
Traverso, CE ;
Franzi, AT ;
Zingirian, M ;
Cancedda, R ;
DeLuca, M .
LANCET, 1997, 349 (9057) :990-993
[25]   Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface [J].
Pellegrini, G ;
Golisano, O ;
Paterna, P ;
Lambiase, A ;
Bonini, S ;
Rama, P ;
De Luca, M .
JOURNAL OF CELL BIOLOGY, 1999, 145 (04) :769-782
[26]   SERIAL CULTIVATION OF STRAINS OF HUMAN EPIDERMAL KERATINOCYTES - FORMATION OF KERATINIZING COLONIES FROM SINGLE CELLS [J].
RHEINWALD, JG ;
GREEN, H .
CELL, 1975, 6 (03) :331-344
[27]   ADHESION AND SPREADING OF HUMAN SKIN FIBROBLASTS ON PHYSICOCHEMICALLY CHARACTERIZED GRADIENT SURFACES [J].
RUARDY, TG ;
SCHAKENRAAD, JM ;
VANDERMEI, HC ;
BUSSCHER, HJ .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (11) :1415-1423
[28]   Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease [J].
Schwab, IR ;
Reyes, M ;
Isseroff, RR .
CORNEA, 2000, 19 (04) :421-426
[29]   Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer [J].
Suggs, LJ ;
West, JL ;
Mikos, AG .
BIOMATERIALS, 1999, 20 (07) :683-690
[30]  
Sun YH, 1999, J APPL POLYM SCI, V74, P2826, DOI 10.1002/(SICI)1097-4628(19991213)74:12<2826::AID-APP6>3.0.CO